Literature DB >> 7753795

Borrelia burgdorferi genes selectively expressed in the infected host.

K Suk1, S Das, W Sun, B Jwang, S W Barthold, R A Flavell, E Fikrig.   

Abstract

An immunological screening strategy was used to select microbial genes expressed only in the host. Differential screening of a Borrelia burgdorferi (the Lyme disease agent) expression library identified a gene (p21) encoding a 20.7-kDa antigen that reacted with antibodies in serum from actively infected mice but not serum from mice immunized with heat-killed B. burgdorferi. Selective expression of p21 in the infected host was confirmed by Northern blot analysis and RNA PCR. Further differential screening of the expression library identified at least five additional B. burgdorferi genes are selectively expressed in vivo. This screening method can be used to identify genes induced in vivo in a wide variety of pathogenic microorganisms for which a gene transfer system is not currently available.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7753795      PMCID: PMC41925          DOI: 10.1073/pnas.92.10.4269

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  13 in total

1.  Protection of mice against the Lyme disease agent by immunizing with recombinant OspA.

Authors:  E Fikrig; S W Barthold; F S Kantor; R A Flavell
Journal:  Science       Date:  1990-10-26       Impact factor: 47.728

2.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

3.  Selection of bacterial virulence genes that are specifically induced in host tissues.

Authors:  M J Mahan; J M Slauch; J J Mekalanos
Journal:  Science       Date:  1993-01-29       Impact factor: 47.728

Review 4.  Lyme disease.

Authors:  A C Steere
Journal:  N Engl J Med       Date:  1989-08-31       Impact factor: 91.245

5.  Low-passage-associated proteins of Borrelia burgdorferi B31: characterization and molecular cloning of OspD, a surface-exposed, plasmid-encoded lipoprotein.

Authors:  S J Norris; C J Carter; J K Howell; A G Barbour
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

6.  Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochaete Borrelia burgdorferi.

Authors:  S Bergström; V G Bundoc; A G Barbour
Journal:  Mol Microbiol       Date:  1989-04       Impact factor: 3.501

7.  Outer surface proteins E and F of Borrelia burgdorferi, the agent of Lyme disease.

Authors:  T T Lam; T P Nguyen; R R Montgomery; F S Kantor; E Fikrig; R A Flavell
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

8.  Structure, chromosome location, and expression of the human gamma-actin gene: differential evolution, location, and expression of the cytoskeletal beta- and gamma-actin genes.

Authors:  H P Erba; R Eddy; T Shows; L Kedes; P Gunning
Journal:  Mol Cell Biol       Date:  1988-04       Impact factor: 4.272

9.  Changes in infectivity and plasmid profile of the Lyme disease spirochete, Borrelia burgdorferi, as a result of in vitro cultivation.

Authors:  T G Schwan; W Burgdorfer; C F Garon
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

10.  A 9.0-kilobase-pair circular plasmid of Borrelia burgdorferi encodes an exported protein: evidence for expression only during infection.

Authors:  C I Champion; D R Blanco; J T Skare; D A Haake; M Giladi; D Foley; J N Miller; M A Lovett
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

View more
  90 in total

1.  Molecular and immunological analyses of the Borrelia turicatae Bdr protein family.

Authors:  J A Carlyon; D M Roberts; M Theisen; C Sadler; R T Marconi
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

2.  Molecular and evolutionary characterization of the cp32/18 family of supercoiled plasmids in Borrelia burgdorferi 297.

Authors:  M J Caimano; X Yang; T G Popova; M L Clawson; D R Akins; M V Norgard; J D Radolf
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

3.  Mutation and recombination in the upstream homology box-flanked ospE-related genes of the Lyme disease spirochetes result in the development of new antigenic variants during infection.

Authors:  S Y Sung; J V McDowell; J A Carlyon; R T Marconi
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

4.  Molecular and evolutionary analysis of Borrelia burgdorferi 297 circular plasmid-encoded lipoproteins with OspE- and OspF-like leader peptides.

Authors:  D R Akins; M J Caimano; X Yang; F Cerna; M V Norgard; J D Radolf
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

5.  Identification of 11 pH-regulated genes in Borrelia burgdorferi localizing to linear plasmids.

Authors:  J A Carroll; R M Cordova; C F Garon
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

Review 6.  Challenge of investigating biologically relevant functions of virulence factors in bacterial pathogens.

Authors:  R Moxon; C Tang
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-05-29       Impact factor: 6.237

Review 7.  Measurement of bacterial gene expression in vivo.

Authors:  I Hautefort; J C Hinton
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-05-29       Impact factor: 6.237

Review 8.  Spirochaetal lipoproteins and pathogenesis.

Authors:  D A Haake
Journal:  Microbiology       Date:  2000-07       Impact factor: 2.777

9.  Borrelia burgdorferi population dynamics and prototype gene expression during infection of immunocompetent and immunodeficient mice.

Authors:  Emir Hodzic; Sunlian Feng; Kim J Freet; Stephen W Barthold
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

10.  Lyme disease-causing Borrelia species encode multiple lipoproteins homologous to peptide-binding proteins of ABC-type transporters.

Authors:  J A Kornacki; D B Oliver
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.